Next-Generation Biomanufacturing Market, By Workflow Type (Upstream Biomanufacturing Workflow and Downstream Biomanufacturing Workflow), By Application, By Product, By End Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV4931
|
Published Date
March 2026
|
Pages
387
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Next-Generation Biomanufacturing Market size was valued at US$ 44,380.39 Million in 2025, expanding at a CAGR of 6.81% from 2026 to 2033.
Next-generation biomanufacturing refers to the application of advanced technologies and modern production methods for the manufacture of biological products, including vaccines, monoclonal antibodies, gene therapies, and other biopharmaceuticals. Unlike traditional biomanufacturing, which often relies on large, time-intensive batch processes, next-generation approaches focus on flexible, efficient, and scalable production systems. Technologies such as continuous bioprocessing, single-use bioreactors, automation, digital monitoring, and advanced cell-culture techniques enhance manufacturing efficiency, ensure consistent product quality, and meet the growing demand for complex biologics used in areas such as oncology, rare diseases, and personalized medicine.
The Next-Generation Biomanufacturing Market is expanding steadily, driven by the increasing demand for biologic drugs and the adoption of advanced manufacturing technologies by pharmaceutical companies to support specialized production processes. Furthermore, rising investments in biotechnology research, the expansion of biopharmaceutical manufacturing facilities, and strategic collaborations between biotech firms and contract manufacturing organizations (CMOs) are facilitating broader adoption of these technologies in modern biopharmaceutical production.
Next-Generation Biomanufacturing Market- Market Dynamics
Increasing Global Demand for Biologics and Advanced Therapies
A key driver of the Next-Generation Biomanufacturing Market is the rapidly increasing global demand for biologic medicines, including monoclonal antibodies, vaccines, and gene and cell therapies. As healthcare systems increasingly rely on advanced biologic treatments for conditions such as cancer, autoimmune disorders, and infectious diseases, pharmaceutical manufacturers are seeking more efficient and scalable production technologies. Next-generation biomanufacturing methods, such as continuous processing, automation, and modular manufacturing systems, offer faster production cycles, higher product quality, and greater operational flexibility compared with traditional batch manufacturing.
This growing demand has particularly strengthened the continuous upstream biomanufacturing segment, which leads the market by enabling large-scale biologics production with improved operational efficiency and a smaller facility footprint, representing approximately 45.3% of the total market share. Government and global health data further underscore the rising importance of biologics production. According to the World Health Organization (WHO), global biopharmaceutical manufacturing capacity has increased by over 30% due to investments in flexible and modular production technologies. Additionally, the U.S. National Institutes of Health (NIH) reports that continuous bioprocessing can reduce manufacturing cycle times by up to 50%, significantly improving efficiency in biologic drug production. These trends indicate that the combination of rising biologics demand and increasing government investment in advanced manufacturing infrastructure is accelerating the global adoption of next-generation biomanufacturing technologies.
Next-Generation Biomanufacturing Market- Segmentation Analysis:
The Global Next-Generation Biomanufacturing Market is segmented on the basis of Product, Application, Workflow Type, End Use, and Region.
The Next-Generation Biomanufacturing Market is segmented by product type into three categories: Continuous Upstream Biomanufacturing Products, Single-Use Upstream Biomanufacturing Products, and Downstream Biomanufacturing Products. Among these, the Single-Use Upstream Biomanufacturing Products segment dominates the global market. This leadership is driven by the ability of single-use systems—such as disposable bioreactors, single-use bags, and tubing—to reduce contamination risks, lower operational costs, and enhance manufacturing flexibility. By eliminating the need for complex cleaning and sterilization processes associated with traditional stainless-steel systems, single-use technologies significantly shorten production cycles and improve operational efficiency. These advantages are particularly critical for the production of monoclonal antibodies, vaccines, and cell and gene therapies. Industry data supports this trend: according to the U.S. Food and Drug Administration (FDA), the number of approved biologics and biosimilar products has steadily increased in recent years, driving demand for faster and more adaptable manufacturing platforms. Additionally, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) reports that biologics constitute a rapidly growing share of global pharmaceutical pipelines, further encouraging manufacturers to adopt single-use technologies to accelerate production and scale operations efficiently. These benefits make single-use upstream systems the most widely implemented product category in next-generation biomanufacturing facilities worldwide.
From an application perspective, the market is categorized into Monoclonal Antibodies, Vaccines, Recombinant Proteins, and Hormones. The monoclonal antibodies (mAbs) segment holds a leading position, driven by their extensive use in treating cancer, autoimmune disorders, and infectious diseases. Biopharmaceutical companies are increasingly prioritizing monoclonal antibody development due to their high specificity, strong therapeutic efficacy, and growing regulatory approvals worldwide. According to the U.S. FDA, monoclonal antibodies account for a significant share of newly approved biologic drugs in recent years, reflecting strong global demand for antibody-based therapies. Furthermore, the World Health Organization (WHO) highlights the expanding use of monoclonal antibody treatments in oncology and immune-related diseases, increasing the need for large-scale and efficient biomanufacturing platforms. Because these therapies require highly controlled and scalable production processes, manufacturers are adopting advanced upstream and downstream biomanufacturing technologies, reinforcing the dominance of the monoclonal antibodies segment in the global market.
Next-Generation Biomanufacturing Market- Geographical Insights
The Next-Generation Biomanufacturing Market demonstrates significant geographical expansion, with North America holding a prominent share. This leadership is supported by the region’s established biotechnology and pharmaceutical sectors, advanced research infrastructure, and robust regulatory framework. The United States plays a key role, driven by investments in biologics, cell and gene therapy development, and adoption of modern manufacturing technologies such as continuous bioprocessing and single-use systems. Government initiatives and funding from organizations like the U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) further facilitate the development of advanced biomanufacturing capabilities.
Europe is another significant market, bolstered by its well-established pharmaceutical industry and collaborative research initiatives. Countries including Germany, the United Kingdom, Switzerland, and France are actively engaged in biologics production and biopharmaceutical research. Government programs, academic institutions, and contract development and manufacturing organizations (CDMOs) are driving the steady adoption of next-generation biomanufacturing technologies across the region, reinforcing Europe’s important role in the global market.
Next-Generation Biomanufacturing Market- Country Insights
In the global Next-Generation Biomanufacturing Market, the United States is a key country due to its well-established biotechnology sector, advanced research infrastructure, and sustained investment in biologics manufacturing technologies. The country is home to numerous biopharmaceutical companies, research institutions, and contract development and manufacturing organizations (CDMOs) that drive the development and production of biologics, vaccines, and cell and gene therapies. Government initiatives further support market growth; for example, the U.S. Department of Health and Human Services (HHS) has implemented programs to strengthen domestic biomanufacturing capabilities and promote innovation in advanced manufacturing technologies. Additionally, collaborations among academic institutions, biotechnology firms, and research organizations are facilitating the adoption of next-generation biomanufacturing methods, including continuous processing, automation, and single-use bioprocessing systems, enhancing efficiency and scalability in biologics production.
Next-Generation Biomanufacturing Market- Competitive Landscape:
The Next-Generation Biomanufacturing Market is highly competitive and moderately fragmented, with numerous global biotechnology and life sciences companies focusing on technological innovation, automation, and advanced bioprocessing solutions to strengthen their market position. Leading players such as Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Sartorius AG, and GE HealthCare provide sophisticated bioreactors, single-use manufacturing systems, and automated platforms for biologics production. These companies employ strategies including collaborations, new product launches, capacity expansions, and strategic acquisitions to enhance manufacturing efficiency and scalability. Key industry players are increasingly investing in continuous biomanufacturing technologies, AI-driven process monitoring, and flexible modular production facilities to meet the growing global demand for biologics, biosimilars, and cell and gene therapies. Such initiatives are intensifying competition while driving technological advancements across the sector.
Recent Developments:
- March 2023: Sartorius AG partnered with LFB Biomanufacturing, a division of LFB Group, a leading European company specializing in plasma-derived pharmaceuticals and therapeutic protein production, to develop and produce cell lines. This collaboration enhances advanced cell line development capabilities and supports the increasing demand for efficient biologics manufacturing within the global biopharmaceutical industry.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Applikon Biotechnology BV (Netherlands),
- bbi-biotech GmbH (Germany),
- Danaher Corporation (US),
- Eppendorf AG (Germany), Esco Group of Companies (US),
- GEA Group Aktiengesellschaft (Germany),
- Meissner Filtration Products, Inc. (US),
- Merck KGaA (Germany),
- PBS Biotech, Inc. (US),
- Pierre Guérin (France),
- Sartorius AG (Germany),
- Shanghai Bailun Biotechnology Co. Ltd. (China),
- Solaris Biotechnology Srl. (Italy),
- Thermo Fisher Scientific Inc. (US),
- ZETA GmbH (Austria),
- Others
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY WORKFLOW TYPE- MARKET ANALYSIS, 2020 - 2033
- Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Monoclonal Antibodies
- Vaccines
- Recombinant Protein
- Hormones
- Others
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Continuous Upstream Biomanufacturing Products
- Single-Use Upstream Biomanufacturing Products
- Downstream Biomanufacturing Products
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY End Use- MARKET ANALYSIS, 2020 - 2033
- Biopharmaceutical Companies
- Research Institutions
- Contract Research Organizations
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Next-Generation Biomanufacturing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Next-Generation Biomanufacturing Market Snippet by Workflow Type
2.1.2. Next-Generation Biomanufacturing Market Snippet by Application
2.1.3. Next-Generation Biomanufacturing Market Snippet by Product
2.1.4. Next-Generation Biomanufacturing Market Snippet by End Use
2.1.5. Next-Generation Biomanufacturing Market Snippet by Country
2.1.6. Next-Generation Biomanufacturing Market Snippet by Region
2.2. Competitive Insights
3. Next-Generation Biomanufacturing Key Market Trends
3.1. Next-Generation Biomanufacturing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Next-Generation Biomanufacturing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Next-Generation Biomanufacturing Market Opportunities
3.4. Next-Generation Biomanufacturing Market Future Trends
4. Next-Generation Biomanufacturing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Next-Generation Biomanufacturing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Next-Generation Biomanufacturing Market Landscape
6.1. Next-Generation Biomanufacturing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Next-Generation Biomanufacturing Market – By Workflow Type
7.1. Overview
7.1.1. Segment Share Analysis, By Workflow Type, 2025 & 2033 (%)
7.1.2. Upstream Biomanufacturing Workflow
7.1.3. Downstream Biomanufacturing Workflow
8. Next-Generation Biomanufacturing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Monoclonal Antibodies
8.1.3. Vaccines
8.1.4. Recombinant Protein
8.1.5. Hormones
8.1.6. Others
9. Next-Generation Biomanufacturing Market – By Product
9.1. Overview
9.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
9.1.2. Continuous Upstream Biomanufacturing Products
9.1.3. Single-Use Upstream Biomanufacturing Products
9.1.4. Downstream Biomanufacturing Products
10. Next-Generation Biomanufacturing Market – By End Use
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
10.1.2. Biopharmaceutical Companies
10.1.3. Research Institutions
10.1.4. Contract Research Organizations
11. Next-Generation Biomanufacturing Market– By Geography
10.2. Introduction
10.2.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.3. North America
10.3.1. Overview
10.3.2. Next-Generation Biomanufacturing Key Manufacturers in North America
10.3.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. North America Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.3.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.6. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.7. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.8. U.S.
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. U.S. Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.3.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.8.5. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.8.6. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.9. Canada
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. Canada Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.3.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.9.5. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.3.9.6. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4. Europe
10.4.1. Overview
10.4.2. Next-Generation Biomanufacturing Key Manufacturers in Europe
10.4.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. Europe Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.4.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.6. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.7. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.8. Germany
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. Germany Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.4.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.8.5. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.8.6. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.9. UK
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. UK Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.4.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.9.5. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.9.6. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.10. France
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. France Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.4.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.10.5. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.10.6. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.11. Italy
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Italy Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.4.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.11.5. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.11.6. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.12. Spain
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Spain Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.4.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.12.5. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.12.6. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.13. The Netherlands
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. The Netherlands Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.4.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.13.5. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.13.6. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.14. Sweden
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Sweden Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.4.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.14.5. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.14.6. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.15. Russia
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Russia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.4.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.15.5. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.15.6. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.16. Poland
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Poland Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.4.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.16.5. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.16.6. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.17. Rest of Europe
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of the Europe Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.4.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.4.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5. Asia Pacific (APAC)
10.5.1. Overview
10.5.2. Next-Generation Biomanufacturing Key Manufacturers in Asia Pacific
10.5.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. APAC Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.5.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.6. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.7. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.8. China
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. China Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.5.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.8.5. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.8.6. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.9. India
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. India Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.5.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.9.5. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.9.6. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.10. Japan
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Japan Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.5.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.10.5. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.10.6. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.11. South Korea
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. South Korea Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.5.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.11.5. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.11.6. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.12. Australia
10.5.12.1. Overview
10.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.12.3. Australia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.5.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.12.5. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.12.6. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.13. Indonesia
10.5.13.1. Overview
10.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.13.3. Indonesia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.5.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.13.5. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.13.6. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.14. Thailand
10.5.14.1. Overview
10.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.14.3. Thailand Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.5.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.14.5. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.14.6. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.15. Philippines
10.5.15.1. Overview
10.5.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.15.3. Philippines Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.5.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.15.5. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.15.6. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.16. Rest of APAC
10.5.16.1. Overview
10.5.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.16.3. Rest of APAC Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.5.16.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.16.5. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.5.16.6. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6. Latin America (LATAM)
10.6.1. Overview
10.6.2. Next-Generation Biomanufacturing Key Manufacturers in Latin America
10.6.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. LATAM Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.6.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.6. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.7. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.8. Brazil
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. Brazil Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.6.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.8.5. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.8.6. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.9. Mexico
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Mexico Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.6.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.9.5. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.9.6. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.10. Argentina
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Argentina Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.6.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.10.5. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.10.6. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.11. Colombia
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Colombia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.6.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.11.5. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.11.6. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.12. Rest of LATAM
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Rest of LATAM Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.6.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.12.5. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.6.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.7. Middle East and Africa (MEA)
10.7.1. Overview
10.7.2. Next-Generation Biomanufacturing Key Manufacturers in Middle East and Africa
10.7.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.7.4. MEA Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.7.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.7.6. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.7.7. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.7.8. Saudi Arabia
10.7.8.1. Overview
10.7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.7.8.3. Saudi Arabia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.7.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.7.8.5. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.7.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.7.9. United Arab Emirates
10.7.9.1. Overview
10.7.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.7.9.3. United Arab Emirates Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.7.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.7.9.5. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.7.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.7.10. Israel
10.7.10.1. Overview
10.7.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.7.10.3. Israel Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.7.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.7.10.5. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.7.10.6. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.7.11. Turkey
10.7.11.1. Overview
10.7.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.7.11.3. Turkey Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.7.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.7.11.5. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.7.11.6. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.7.12. Algeria
10.7.12.1. Overview
10.7.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.7.12.3. Algeria Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.7.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.7.12.5. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.7.12.6. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.7.13. Egypt
10.7.13.1. Overview
10.7.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.7.13.3. Egypt Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.7.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.7.13.5. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.7.13.6. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.7.14. Rest of MEA
10.7.14.1. Overview
10.7.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.7.14.3. Rest of MEA Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
10.7.14.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.7.14.5. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
10.7.14.6. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- Next-Generation Biomanufacturing Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.3. Applikon Biotechnology BV (Netherlands),
11.4. bbi-biotech GmbH (Germany),
11.5. Danaher Corporation (US),
11.6. Eppendorf AG (Germany), Esco Group of Companies (US),
11.7. GEA Group Aktiengesellschaft (Germany),
11.8. Meissner Filtration Products, Inc. (US),
11.9. Merck KGaA (Germany),
11.10. PBS Biotech, Inc. (US),
11.11. Pierre Guérin (France),
11.12. Sartorius AG (Germany),
11.13. Shanghai Bailun Biotechnology Co. Ltd. (China),
11.14. Solaris Biotechnology Srl. (Italy),
11.15. Thermo Fisher Scientific Inc. (US),
11.16. ZETA GmbH (Austria),
11.17. Other
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Applikon Biotechnology BV (Netherlands),
- bbi-biotech GmbH (Germany),
- Danaher Corporation (US),
- Eppendorf AG (Germany), Esco Group of Companies (US),
- GEA Group Aktiengesellschaft (Germany),
- Meissner Filtration Products, Inc. (US),
- Merck KGaA (Germany),
- PBS Biotech, Inc. (US),
- Pierre Guérin (France),
- Sartorius AG (Germany),
- Shanghai Bailun Biotechnology Co. Ltd. (China),
- Solaris Biotechnology Srl. (Italy),
- Thermo Fisher Scientific Inc. (US),
- ZETA GmbH (Austria),
- Others
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY WORKFLOW TYPE- MARKET ANALYSIS, 2020 - 2033
- Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Monoclonal Antibodies
- Vaccines
- Recombinant Protein
- Hormones
- Others
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Continuous Upstream Biomanufacturing Products
- Single-Use Upstream Biomanufacturing Products
- Downstream Biomanufacturing Products
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY End Use- MARKET ANALYSIS, 2020 - 2033
- Biopharmaceutical Companies
- Research Institutions
- Contract Research Organizations
GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
